Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study
In their excellent study (the GALILEO trial), Ogura and associates prospectively evaluated the efficacy and safety of intravitreal aflibercept (IVA; VEGF Trap-Eye: Regeneron Pharmaceuticals, Inc, Tarrytown, New York, USA and…